Lapo Alinari

6PUBLICATIONS
86CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 14, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

|Feb 04, 2026
Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexate.

Zachary J Arnold, Jordan Lundberg, Tracy Wiczer

|Aug 26, 2025
The Novel Immunocompetent Eµ-SOX11CCND1 Mouse Model Phenotypically and Molecularly Resembles Human Mantle Cell Lymphoma.

Hedieh Jafari, Fiona Brown-Burke, Betsy Pray

|Jul 07, 2023
T Cell-intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia.

Vi Lam, Carly Roleder, Tingting Liu

|Jun 10, 2023
Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein-Barr Virus Lymphoproliferative Disorder.

Elshafa Hassan Ahmed, Mark Lustberg, Claire Hale

|Mar 11, 2023
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.

Walter Hanel, Polina Shindiapina, David A Bond

Pageof 1

Frequent Collaborators

3 joint publications

Walter Hanel

3 joint publications

Yazeed Sawalha

3 joint publications

Narendranath Epperla

3 joint publications

Timothy Voorhees